In practice, because the majority of G6PD-deficient persons are mostly asymptomatic, their G6PD deficiency is referred to as mild, simple, or common (corresponding to class II or III)
Much of the support for localized injections is anecdotal
Additional Potential Benefits Beyond sleep and stress, DSIP may provide other systemic advantages: Pain management: Preliminary studies suggest DSIP could influence pain pathways, potentially lowering pain perception
Those discussions typically mix opinions, anecdotes, and personal speculation, and they should not be confused with formal research or professional guidance
In a 2-year trial involving patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk, more events of diabetic retinopathy complications occurred in patients treated with semaglutide 0.5 and 1 mg once weekly injections (3%) compared to placebo (1.8%)